Clinical Trial Update: A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating androgen deprivation with leuprolide with or without docetaxel in clinically asymptomatic prostate cancer patients with rising PSA; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2013-11-04